Fiona Cody

ORCID: 0000-0002-3615-2618
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Maternal and Perinatal Health Interventions
  • Birth, Development, and Health
  • Prenatal Screening and Diagnostics
  • Gestational Diabetes Research and Management
  • Maternal and fetal healthcare
  • Cardiovascular Issues in Pregnancy
  • Congenital Heart Disease Studies
  • Pregnancy-related medical research
  • Assisted Reproductive Technology and Twin Pregnancy
  • Hip disorders and treatments
  • Fetal and Pediatric Neurological Disorders
  • Cancer Risks and Factors
  • Cardiac Structural Anomalies and Repair
  • Congenital Anomalies and Fetal Surgery
  • Cleft Lip and Palate Research
  • Pelvic floor disorders treatments
  • Ectopic Pregnancy Diagnosis and Management
  • Autopsy Techniques and Outcomes
  • Cardiovascular Conditions and Treatments
  • Hip and Femur Fractures
  • Nursing Roles and Practices
  • Hospital Admissions and Outcomes
  • Neonatal Respiratory Health Research
  • Cardiac, Anesthesia and Surgical Outcomes

Rotunda Hospital
2013-2024

Royal College of Surgeons in Ireland
2015-2024

Royal Women's Hospital
2021

The University of Melbourne
2021

Wright State University
2015

Christiana Care Health System
2015

Cincinnati Children's Hospital Medical Center
2015

Coombe Women & Infants University Hospital
2015

University of Miami
2015

Medical University of South Carolina
2015

Maternal obesity represents a challenge in the sonographic (US) assessment of fetal weight, and is recognized risk factor for adverse pregnancy outcome. The objective this secondary analysis data from Prospective Observational Trial to Optimize Pediatric Health growth restriction (FGR) Study (PORTO) was describe effect maternal on accuracy US determining estimated weight (EFW) perinatal outcome pregnancies affected by FGR.Between 2010 2012, 1,116 women with nonanomalous singleton an EFW less...

10.1002/jcu.22273 article EN Journal of Clinical Ultrasound 2015-07-14

Objective Evaluate the feasibility and acceptability of routine aspirin in low-risk women, compared with screening-test indicated for prevention pre-eclampsia fetal growth restriction. Design Multicentre open-label randomised controlled trial. Setting Two tertiary maternity hospitals Dublin, Ireland. Participants 546 nulliparous women completed study. Interventions Women underwent computerised randomisation to: Group 1—routine 75 mg from 11 until 36 weeks; 2—no and; 3—aspirin based on Fetal...

10.1136/bmjopen-2018-022056 article EN cc-by-nc BMJ Open 2018-07-01

Prenatal detection of critical congenital heart disease (CCHD) optimises perinatal decision-making and neonatal outcomes. The objective this study was to determine the prenatal screening performance, care pathways outcomes for prenatally postnatally diagnosed cases CCHD over a four-year period.

10.1186/s12884-024-06350-0 article EN cc-by BMC Pregnancy and Childbirth 2024-02-24

We have shown previously that third-trimester growth in small fetuses (estimated fetal weight (EFW) < 10th percentile) with birth (BW) percentile is heterogeneous using individualized assessment (IGA). aimed to test our hypothesis individual patterns BW > are also variable but different ways.This was a study of 191 cases EFW and (appropriate-for-gestational-age (AGA) cohort), derived from the PORTO study. Composite size parameters were used quantify pathology at timepoints (individual...

10.1002/uog.23688 article EN Ultrasound in Obstetrics and Gynecology 2021-05-17

Objective This article evaluates the effect of low-dose aspirin on uterine artery (UtA) Doppler, placental volume, and vascularization flow indices in low-risk pregnancy. Study Design In this secondary analysis TEST randomized controlled trial, nulliparous women were originally at 11 weeks to: (1) routine 75 mg; (2) no aspirin; (3) based upon preeclampsia Fetal Medicine Foundation screening test. UtA three-dimensional (3D) assessed prior to 6 postaspirin commencement. Results A total 546...

10.1055/s-0038-1675208 article EN American Journal of Perinatology 2018-11-05

Fetal growth restriction is being defined as either "early" or "late" depending on age of onset. A recent investigation using individualized assessment has identified five different patterns. No previous study related these patterns to cardiovascular abnormalities.To determine in small fetuses (BW < 10th percentile) Individualized Growth Assessment (IGA) and relate abnormalities found with Doppler ultrasound patterns.A secondary analysis was carried out 126 from the PORTO data set having...

10.1080/14767058.2019.1677592 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2019-10-21

Increased fetal size is associated with shoulder dystocia during labor and subsequent need for assisted delivery. We sought to investigate if increased adiposity diagnosed sonographically in late pregnancy risk of operative delivery.This secondary analysis the Genesis Study recruited 2392 nulliparous women singleton cephalic presentation, a prospective, multicenter study, examine prenatal intrapartum predictors Cesarean Participants underwent ultrasound clinical evaluation between 39 + 0 40...

10.1002/uog.20263 article EN Ultrasound in Obstetrics and Gynecology 2019-03-19

To characterize growth processes and their associated cardiovascular abnormalities in SGA fetuses with normal progressive restriction patterns as defined by Individualized Growth Assessment (IGA).A cohort (EFW BW < 10th percentile) was derived from the PORTO study that included 47 outcome (SGA Normal) 34 Restricted, Pattern 1). Composite fetal size parameters were used to quantify pathology at individual third trimester time points (individual composite Prenatal Score {icPGAS}) calculated...

10.1080/14767058.2020.1807506 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2020-09-13

Abstract Background The RECIPE study aims to validate a risk prediction model for intrapartum caesarean delivery which has been developed by our group. Genesis was prospective observational carried out the Perinatal Ireland Research Consortium across 7 clinical centres in between October 2012 and June 2015. investigated range of maternal fetal parameters blinded 2336 singleton pregnancies 39 + 0–41 0 weeks’ gestational age. This resulted development Caesarean Delivery nulliparous women at...

10.1186/s12884-020-03112-6 article EN cc-by BMC Pregnancy and Childbirth 2020-07-29

To characterize abnormal growth processes and their associated cardiovascular abnormalities in SGA fetuses using Individualized Growth Assessment (IGA).This longitudinal investigation utilized a cohort [EFW BW <10th percentile] derived from the PORTO study. Fetuses categorized by Fetal Pathology Score [FGPS1] patterns [Pattern 2 {n = 12}, Pattern 3 11}, 5 13}] were evaluated. pathology was measured -FGPS1 individual composite Prenatal {-icPGAS]. Paired assessments measurements of Pulsatility...

10.1080/14767058.2020.1803262 article EN The Journal of Maternal-Fetal & Neonatal Medicine 2020-09-16
Coming Soon ...